Status:
COMPLETED
The Effect of Fish Oil Supplementation on Endothelial Function, Heart Rate Variability and Intimal Media Thickness of Patients With Coronary Artery Disease
Lead Sponsor:
Olive View-UCLA Education & Research Institute
Collaborating Sponsors:
Reliant Pharmaceuticals
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The purpose of this study is to investigate whether there is a difference in endothelial function, heart rate variability and carotid intimal media thickness in patients with coronary artery disease w...
Eligibility Criteria
Inclusion
- Established coronary artery disease as determined by coronary angiography within the last 5 years demonstrating at least 50% stenosis in one of the major coronary vessels
- Age \>18 and \<75.
Exclusion
- Baseline fish oil intake ≥1g/day or fish intake \>100g/day
- Need for urgent or emergent CABG
- Contraindication for plavix, aspirin or statin
- Gastrointestinal malabsorption syndrome
- Pregnancy
- Oral contraceptive use
- Ejection fraction \<40%
- Underlying atrial or ventricular arrhythmia
- History of rheumatoid arthritis
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT00454493
Start Date
August 1 2006
End Date
December 1 2008
Last Update
March 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
OV-UCLA Medical Center
Sylmar, California, United States, 91342